Randomized, Placebo-controlled, Observer-blinded Phase 1 Safety and Immunogenicity Study of Inactivated Zika Virus Vaccine Candidate in Healthy Adults
Clinical trial NCT03425149 · COMPLETED
Trial details
- NCT number
- NCT03425149
- Sponsor
- Valneva Austria GmbH
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-24
- Primary completion
- 2018-06-26
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.